What You Should Know:
–Koda Health, a digital health company building an AI-enhanced patient decision support platform that enables health systems and payers to scale advanced care planning (ACP) and goals-of-care conversations secures $7M in Series A funding round led by Evidenced, with participation from Mudita Venture Partners, Techstars, and Texas Medical Center.
– The new capital will enable Koda to scale its operations and meet surging demand nationwide. To support this growth, Koda is also investing in organizational expansion across engineering, clinical strategy, and customer success — building the capacity to deliver its goals-of-care solutions at true population scale.
Tackling One of Healthcare’s Costliest Gaps
Founded in 2020 by Tatiana Fofanova, PhD; Desh Mohan, MD; and Katelin Cherry through the Texas Medical Center Biodesign Program, Koda Health has grown from a small team of innovators into a national platform reshaping how serious illness care is delivered. With powerful policy momentum — including CMS reimbursement for Advance Care Planning and value-based models that reward goal-concordant care — Koda is redefining how the healthcare system honors patient voices at scale.
Serious illness care remains one of the most fragmented and expensive areas of U.S. healthcare, with over $200 billion wasted annually on unwanted or inappropriate interventions. Too often, patients face critical decisions without sufficient support, leading to treatments that conflict with their goals, add strain to families, and drive unsustainable costs.
Koda closes this gap with an EMR-integrated patient decision support platform that delivers education, facilitates informed choices, and generates legally valid documentation such as Advance Directives, DNRs, and Medical Power of Attorney forms. Patients can finalize decisions asynchronously, virtually notarize documents, and securely share them — ensuring preferences guide care when it matters most. With one in four healthcare dollars spent in the last year of life, this alignment can reduce costs by more than 40%, unlocking billions in savings nationwide.
“Koda ensures patients’ voices guide care in the moments that matter most, tackling a long-overlooked challenge in healthcare,” said Tatiana Fofanova, PhD, co-founder and CEO of Koda Health. “This funding allows us to create more goals-of-care product lines, expand our national footprint, and bring goal-concordant care to millions more patients and families.”
Scaling Nationally With Measurable Outcomes
This financing round marks a pivotal moment for Koda Health, led by Evidenced, a venture firm founded by the former CTO of the U.S. Department of Health and Human Services and a serial digital health entrepreneur with multiple exits. Evidenced invests in companies poised to benefit from regulatory and commercial shifts — placing Koda at the center of one of healthcare’s most transformative movements.
Koda’s platform already supports more than one million patients nationwide through partnerships with leading health systems and payers such as Cigna, Privia, Memorial Hermann, and Guidehealth. Peer-reviewed research with Houston Methodist ACO demonstrated significant impact, including:
- 79% reduction in terminal hospitalizations
- 20% decrease in inpatient length of stay
- 51% increase in hospice use among decedents
- $9,000 average savings per patient, equating to a 42% reduction in median total cost of care
Beyond outcomes and ROI, Koda has achieved an industry-leading Net Promoter Score of 87, reflecting exceptional patient satisfaction and trust.
Through condition-specific planning pathways like Kidney Action Planning, the platform empowers patients to align treatment with personal values — whether evaluating dialysis options for kidney disease or balancing cancer treatment against fertility concerns. By connecting care directly to patient priorities, Koda reduces unnecessary interventions, alleviates family burden, and enables providers to deliver truly goal-concordant care.
